Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.390
-0.030 (-2.11%)
Apr 29, 2026, 11:13 AM EDT - Market open
Marker Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 16.07 | 19.19 | 15.11 | 11.78 | 42.35 | Upgrade
|
| Cash & Short-Term Investments | 16.07 | 19.19 | 15.11 | 11.78 | 42.35 | Upgrade
|
| Cash Growth | -16.28% | 27.01% | 28.26% | -72.18% | 98.34% | Upgrade
|
| Other Receivables | 1.37 | 2.35 | 1.03 | 2.4 | 0 | Upgrade
|
| Receivables | 1.37 | 2.35 | 1.03 | 2.4 | 0 | Upgrade
|
| Prepaid Expenses | 0.66 | 0.48 | 0.99 | 1.85 | 2.48 | Upgrade
|
| Restricted Cash | 0.97 | - | - | - | 1.15 | Upgrade
|
| Other Current Assets | - | - | - | 0.59 | - | Upgrade
|
| Total Current Assets | 19.07 | 22.02 | 17.13 | 16.62 | 45.98 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 22.15 | Upgrade
|
| Other Long-Term Assets | - | - | - | 17.8 | - | Upgrade
|
| Total Assets | 19.07 | 22.02 | 17.13 | 34.42 | 68.14 | Upgrade
|
| Accounts Payable | 0.79 | 1.07 | 0.96 | 1.1 | 5.14 | Upgrade
|
| Accrued Expenses | 0.3 | 2.19 | 1.91 | 1.27 | 3.33 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.62 | Upgrade
|
| Current Unearned Revenue | 0.97 | - | - | - | 1.15 | Upgrade
|
| Other Current Liabilities | 0.2 | 0.2 | 0.21 | 5.41 | 2.66 | Upgrade
|
| Total Current Liabilities | 2.27 | 3.46 | 3.07 | 7.78 | 12.9 | Upgrade
|
| Long-Term Leases | - | - | - | - | 11.25 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 7.04 | - | Upgrade
|
| Total Liabilities | 2.27 | 3.46 | 3.07 | 14.82 | 24.15 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 475.96 | 465.56 | 450.33 | 447.64 | 442.1 | Upgrade
|
| Retained Earnings | -459.18 | -447.02 | -436.29 | -428.05 | -398.12 | Upgrade
|
| Shareholders' Equity | 16.8 | 18.56 | 14.05 | 19.6 | 43.99 | Upgrade
|
| Total Liabilities & Equity | 19.07 | 22.02 | 17.13 | 34.42 | 68.14 | Upgrade
|
| Total Debt | - | - | - | - | 11.87 | Upgrade
|
| Net Cash (Debt) | 16.07 | 19.19 | 15.11 | 11.78 | 30.48 | Upgrade
|
| Net Cash Growth | -16.28% | 27.01% | 28.26% | -61.35% | 235.15% | Upgrade
|
| Net Cash Per Share | 1.05 | 2.14 | 1.72 | 1.41 | 3.98 | Upgrade
|
| Filing Date Shares Outstanding | 16.67 | 10.71 | 8.9 | 8.8 | 8.31 | Upgrade
|
| Total Common Shares Outstanding | 16.67 | 10.71 | 8.89 | 8.41 | 8.31 | Upgrade
|
| Working Capital | 16.8 | 18.56 | 14.05 | 8.84 | 33.08 | Upgrade
|
| Book Value Per Share | 1.01 | 1.73 | 1.58 | 2.33 | 5.29 | Upgrade
|
| Tangible Book Value | 16.8 | 18.56 | 14.05 | 19.6 | 43.99 | Upgrade
|
| Tangible Book Value Per Share | 1.01 | 1.73 | 1.58 | 2.33 | 5.29 | Upgrade
|
| Machinery | - | - | - | - | 9.66 | Upgrade
|
| Construction In Progress | - | - | - | - | 2.23 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 3.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.